The MM-II trial was carried out in partnership with Israel-based Moebius Medical and included 397 patients in the US, Europe, ...

If you’re experiencing knee pain, it’s a good idea to look beyond the knees to identify the source of pain and address it, ...

New Delhi: A common diabetes drug can help reduce pain in people with knee osteoarthritis (OA) and obesity, as well as delay ...

A new study has uncovered another benefit of one of the country's most commonly prescribed medications for diabetes - joint ...

A new study has uncovered another benefit of one of the country's most commonly prescribed medications for diabetes - joint pain relief. A man on the Gold Coast has blamed the council for a water leak ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

The diabetes drug metformin provided overweight/obese patients with osteoarthritis (OA) of the knee with significantly greater pain relief than did placebo in a small randomized trial, researchers ...

India's Sun Pharma and Israel's Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis.

The implant is designed to address cartilage defects in the knee that cause persistent pain, according to a press release from the company.

Adolore BioTherapeutics (”Adolore” or the “Company”) is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

Former Olympic athlete Allison Curbishley used to compete for Britain in the 400m, but by last year she was struggling to ...